摘要：美国食品和药物管理局FDA批准了Zykadia（Ceritinib，色瑞替尼）的新的适应症申请，用于ALKFB性的转移性非小细胞肺癌（NSCLC）患者的一线治疗。本次Zykadla一线适应症获批是基于一项开标、随机、国际多中心的临床III期研究ASCEND-4的研究数据。
注：因版权方要求，不能公开全文，如需全文，请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering